Peter Holman

1.3k citations

72 papers · 541 indexed · h-index 14

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Music top 5%
- Musicology and Musical Analysis

Papers in ⓘ

Music 29
- Musicology and Musical Analysis 27
- Diverse Musicological Studies 18
- Theater, Performance, and Music History 11
Genetics 11
- Chronic Lymphocytic Leukemia Research 10

Co-authors: Ewa Carrier (13 shared papers)Edward D. Ball (11 shared papers)Asad Bashey (12 shared papers)Sue Corringham (10 shared papers)Joseph P. McGuirk (2 shared papers)Muna Qayed (2 shared papers)Edmund K. Waller (2 shared papers)Thomas A. Lane (8 shared papers)
Journals: Early Music (13 papers)Blood (8 papers)Biology of Blood and Marrow Transplantation (4 papers)Bone Marrow Transplantation (4 papers)Cytotherapy (4 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Peter Holman

46 papers receiving 506 citations

Peers

Countries citing papers authored by Peter Holman

Since Specialization

Citations

This map shows the geographic impact of Peter Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Holman more than expected).

Fields of papers citing papers by Peter Holman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Holman. The network helps show where Peter Holman may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Holman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Holman Line = papers co-authored together Peter Holman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses Journal of Clinical Oncology ·Charles H. Redfern, Troy H. Guthrie, Alberto Bessudo, John Densmore, Peter Holman, Nalini Janakiraman, John P. Leonard, Ronald Levy, R. Just, Mitchell R. Smith, Fred Rosenfelt, Peter H. Wiernik, William D. Carter, Daniel P. Gold, Teresa J. Melink, John Gutheil, John F. Bender	2006	74
2	AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study. Blood ·Jörge E. Cortes, James M. Foran, Darejan Ghirdaladze, Marcel P. Devetten, Mamia Zodelava, Peter Holman, Mark J. Levis, Hagop M. Kantarjian, Gautam Borthakur, Joyce James, Patrick P Zarringkar, Ruwanthi N. Gunawardane, Robert C. Armstrong, Norman M. Padre, Wendell Wierenga, Robert Corringham, Mohit Trikha	2009	54
3	Building blocks for institutional preparation of CTL019 delivery Cytotherapy ·Joseph P. McGuirk, Edmund K. Waller, Muna Qayed, Sunil Abhyankar, Solveig G. Ericson, Peter Holman, Christopher Hunt Keir, Gary Douglas Myers	2017	53
4	High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma Bone Marrow Transplantation ·Er Wang, Y A Chen, Sue Corringham, Asad Bashey, Peter Holman, Edward D. Ball, Ewa Carrier	2004	44
5	Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing Cytotherapy ·Muna Qayed, Joseph P. McGuirk, Gary D. Myers, Vinod Parameswaran, Edmund K. Waller, Peter Holman, Margarida Rodrigues, Lee Clough, Jennifer Willert	2022	37
6	A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells Oncogene ·Jeffery Chakedis, Robert M. French, Michele Babicky, Dawn Jaquish, H. J. Howard, Evangeline Mose, Raymond W. Lam, Peter Holman, Jaclyn Miyamoto, Zakkary J. Walterscheid, Andrew M. Lowy	2015	32
7	Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies Supportive Care in Cancer ·Joel E. Dimsdale, Edward D. Ball, Ewa Carrier, Mark S. Wallace, Peter Holman, Carolyn Mulroney, Farah Shaikh, Loki Natarajan	2010	20
8	FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia Bone Marrow Transplantation ·M L Tanner, Carl K. Hoh, Asad Bashey, Peter Holman, Catherine Sun, H. Elizabeth Broome, Thomas A. Lane, Edward D. Ball, Ewa Carrier	2003	17
9	Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation Cytotherapy ·Asad Bashey, Sue Corringham, EA Gilpin, Karen K. Fields, Renee Smilee, C. DeFrancisco, O. Santos-Ada, Peter Holman, Ewa Carrier, Anthony D. Ho, Thomas A. Lane, Edward D. Ball, William E. Janssen, Ping‐Yee Law	2000	16
10	Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells Cytotherapy ·Thomas A. Lane, Asad Bashey, Ewa Carrier, Peter Holman, Januario E. Castro, Michael D. Mullen, David M. Ward, O. Ada, Edward D. Ball	2004	15
11	A Biographical Dictionary of English Court Musicians, 1485-1714, Volumes I and II Medical Entomology and Zoology ·Andrew Ashbee, David Lasocki, Peter Holman, Fiona Kisby	1998	15
12	Four and Twenty Fiddlers: The Violin at the English Court 1540 - 1690 The Musical Times ·Jonathan Freeman‐Attwood, Peter Holman	1993	14
13	Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors Bone Marrow Transplantation ·Mitchell E. Horwitz, G D Long, Peter Holman, Edward N. Libby, Gary Calandra, J R Schriber	2012	13
14	Peripheral blood progenitor cell mobilization with intermediate‐dose cyclophosphamide, sequential granulocyte‐macrophage–colony‐stimulating factor and granulocyte–colony‐stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation Transfusion ·Asad Bashey, Michael Donohue, Lin Liu, Bridget Medina, Sue Corringham, Anita Ihasz, Ewa Carrier, Januario E. Castro, Peter Holman, Ronghui Xu, Ping‐Yee Law, Edward D. Ball, Thomas A. Lane	2007	13
15	Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older Leukemia Research ·Asad Bashey, Lin Liu, Anita Ihasz, Bridget Medina, Sue Corringham, Katherine Keese, Ewa Carrier, Januario E. Castro, Peter Holman, Thomas A. Lane, Kamran Hassidim, Edward D. Ball	2005	12
16	Autologous Hematopoietic Stem Cell Transplantation as an Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myelogenous Leukemia Biology of Blood and Marrow Transplantation ·A. Scott Jung, Peter Holman, Januario E. Castro, Ewa Carrier, Asad Bashey, Thomas A. Lane, Connie L. Nelson, Minya Pu, Karen Messer, Sue Corringham, Edward D. Ball	2009	11
17	Four and Twenty Fiddlers Peter Holman	1993	11
18	AUTOLOGOUS BLOOD DONATION IN TOTAL HIP REPLACEMENT Australian and New Zealand Journal of Surgery ·Matthew G. Sharland, Peter Holman	1995	9
19	Noninfectious adverse effects of blood transfusion in the neonate. PubMed ·Peter Holman, M. A. Blajchman, Nancy M. Heddle	1995	9
20	Id/KLH Vaccine (FavId™) Following Treatment with Rituximab: An Analysis of Response Rate Improvement (RRI) and Time-to-Progression (TTP) in Follicular Lymphoma (FL). Blood ·Omer N. Koç, Charles H. Redfern, Peter H. Wiernik, Fred Rosenfelt, Jane N. Winter, Troy H. Guthrie, Lawrence Kaplan, Peter Holman, John Densmore, John D. Hainsworth, Thomas S. Lin, Rene A. Castillo, Nalini Janakiraman, John F. Bender	2004	8

About Peter Holman

Peter Holman is a scholar working on Music, Genetics, Hematology, Pathology and Forensic Medicine and Oncology, having authored 72 papers that have together received 541 indexed citations. Recurring topics across this work include Musicology and Musical Analysis (27 papers), Diverse Musicological Studies (18 papers), Lymphoma Diagnosis and Treatment (11 papers), Theater, Performance, and Music History (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Historical Influence and Diplomacy (7 papers). The work is most often cited by research in Hematology (170 citations), Music (46 citations), Oncology (234 citations), Genetics (72 citations) and Immunology (122 citations). Peter Holman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ewa Carrier, Edward D. Ball, Asad Bashey, Sue Corringham, Joseph P. McGuirk, Muna Qayed, Edmund K. Waller, Thomas A. Lane, Sunil Abhyankar and Solveig G. Ericson. Their work appears in journals such as Early Music, Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation and Cytotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact